Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: PEVAZ: A PHASE II STUDY OF PEVONEDISTAT AND AZACITIDINE IN MDS AND MDS/MPN PATIENTS RELAPSED OR REFRACTORY TO DNMT INHIBITION (DNMTI)

Journal article

Peer reviewed

J. Watts, B. Smith, T. Bradley, B. Skikne, J. Mendler, V. Klimek, A. Thomassen, T. Stopcyzinski, S.-C. Chen, F. Run, …

Leukemia research, Vol.128, p.107272

2023-05

Metrics

2 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Title: Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: PEVAZ: A PHASE II STUDY OF PEVONEDISTAT AND AZACITIDINE IN MDS AND MDS/MPN PATIENTS RELAPSED OR REFRACTORY TO DNMT INHIBITION (DNMTI)
Creators: J. Watts - Sylvester Comprehensive Cancer Center
B. Smith - Vanderbilt-Ingram Cancer Center
T. Bradley - Sylvester Comprehensive Cancer Center
B. Skikne - The University of Kansas Cancer Center
J. Mendler - University of Rochester Medical Center
V. Klimek - Memorial Sloan Kettering Cancer Center
A. Thomassen - Sylvester Comprehensive Cancer Center
T. Stopcyzinski - Vanderbilt-Ingram Cancer Center
S.-C. Chen - Vanderbilt-Ingram Cancer Center
F. Run - Vanderbilt-Ingram Cancer Center
I. Anderson - Vanderbilt-Ingram Cancer Center
A. Moncrief - Vanderbilt-Ingram Cancer Center
S. Madhu - Vanderbilt-Ingram Cancer Center
A. Sochacki - Vanderbilt University
A. Kishtagari - Vanderbilt-Ingram Cancer Center
S. Strickland - Vanderbilt-Ingram Cancer Center
M. Byrne - Vanderbilt-Ingram Cancer Center
G. Ayers - Vanderbilt-Ingram Cancer Center
S. Mohan - Vanderbilt-Ingram Cancer Center
T. Moyo - Vanderbilt-Ingram Cancer Center
M. Savona - Vanderbilt-Ingram Cancer Center
Publication Details: Leukemia research, Vol.128, p.107272
Publisher: Elsevier Ltd; OXFORD
Number of pages: 1
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991032860865202976